Skip to main content
. 2019 Jul 15;14(7):e0219676. doi: 10.1371/journal.pone.0219676

Table 3. Clinical outcomes at 1-year follow-up.

Patients (n = 1050)
Total Mortality, n (%) 71 (6.8)
Cardiovascular Mortality, n (%) 42 (4.0)
Target Lesion Revascularization, n (%) 20 (1.9)
Re-infarction, n (%) 32 (3.0)
TIA, n (%) 1 (0.09)
Ischemic Stroke n (%) 9 (0.9)
Peripheral Embolism, n (%) 2 (0.2)
Hemorrhagic Complications
Major Bleeding 19 (1.8)
TIMI Major, n (%) 15 (1.4)
TIMI Minor, n (%) 13 (1.2)
TIMI Minimal, n (%) 24 (2.3)
GUSTO Severe or Life-threatening, n (%) 12 (1.1)
GUSTO Moderate n (%) 10 (0.9)
GUSTO Mild, n (%) 30 (2.8)
ISTH Cerebral, n (%) 8 (0.7)
ISTH Gastrointestinal, n (%) 7 (0.6)
ISTH Loss of Hgb ≥ 2 g/dL, n (%) 1 (0.09)
ISTH Pericardial, n (%) 1 (0.09)
ISTH Retroperitoneal, n (%) 1 (0.09)
Minor Bleeding 71 (6.8)